Antifibrotic activity of anisodamine in vivo is associated with changed intrahepatic levels of matrix metalloproteinase‐2 and its inhibitor tissue inhibitors of metalloproteinases‐2 and transforming growth factor β1 in rats with carbon tetrachloride‐induced liver injury